CBSTZ Recent News Cellceutix Enrolls First Patien
Post# of 4
Posted On: 03/02/2014 3:04:15 AM
CBSTZ Recent News
Cellceutix Enrolls First Patients in Phase 2b ABSSSI Clinical Trial Marketwire - Wed Feb 26, 5:00AM CST
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics M2 - Tue Feb 18, 2:37AM CST
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 Report M2 - Thu Feb 06, 2:49AM CST
Catabasis Announces Appointment of Kenneth M. Bate as Independent Director PR Newswire - Tue Feb 04, 7:00AM CST
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013 Research Report M2 - Mon Feb 03, 2:25AM CST
Bacteremia - Pipeline Review, H2 2013 Report M2 - Mon Jan 27, 2:14AM CST
Unaudited Results, Partnerships, and Stock Price Movements - Research Report on Cubist, Novavax, Exelixis, BioCryst, and Foundation Medicine PR Newswire - Thu Jan 16, 7:00AM CST
Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD PR Newswire - Wed Jan 08, 7:00AM CST
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind PR Newswire - Tue Dec 31, 7:00AM CST
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals PR Newswire - Thu Dec 19, 7:00AM CST
Cellceutix Enrolls First Patients in Phase 2b ABSSSI Clinical Trial Marketwire - Wed Feb 26, 5:00AM CST
Competitor Analysis: Clostridium Difficile Vaccines and Therapeutics M2 - Tue Feb 18, 2:37AM CST
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) - Pipeline Review, H2 2013 Report M2 - Thu Feb 06, 2:49AM CST
Catabasis Announces Appointment of Kenneth M. Bate as Independent Director PR Newswire - Tue Feb 04, 7:00AM CST
Hospital Acquired Pneumonia (HAP) - Pipeline Review, H2 2013 Research Report M2 - Mon Feb 03, 2:25AM CST
Bacteremia - Pipeline Review, H2 2013 Report M2 - Mon Jan 27, 2:14AM CST
Unaudited Results, Partnerships, and Stock Price Movements - Research Report on Cubist, Novavax, Exelixis, BioCryst, and Foundation Medicine PR Newswire - Thu Jan 16, 7:00AM CST
Technical Dossier: Theravance, Alkermes, Cubist Pharma, and TherapeuticsMD PR Newswire - Wed Jan 08, 7:00AM CST
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind PR Newswire - Tue Dec 31, 7:00AM CST
Regulatory Updates, Clinical Trial Results, and Stock Price Movements - Research Report on Johnson & Johnson, Cubist, Regeneron, Medtronic, and Jazz Pharmaceuticals PR Newswire - Thu Dec 19, 7:00AM CST
(0)
(0)